Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R2 Dermatology has developed and commercialized FDA-cleared devices using proprietary Cryomodulation™ technology for the treatment of benign skin lesions and overall skin lightening. Their Glacial Skin platforms offer a non-invasive alternative to heat-based laser treatments, with clinical results showing effective reduction in visible signs of aging and pigmentation with minimal side effects or downtime. Results are typically seen within 1–2 months and sustained with ongoing care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R2 Dermatology.